VRNA

Verona Pharma

37 hedge funds and large institutions have $234M invested in Verona Pharma in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.

Holders
37
Holders Change
Holders Change %
0%
% of All Funds
0.65%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
6
Increased
5
Reduced
6
Closed
6
Calls
$4K
Puts
$35K
Net Calls
-$31K
Net Calls Change
+$69K
Name Market Value Shares Shares
Change
Shares
Change %
CPIG
26
Chicago Partners Investment Group
Illinois
$58K 10,006 +10,006 New
RE
27
RBC Europe
United Kingdom
$28.9K 4,415
US Bancorp
28
US Bancorp
Minnesota
$25K 3,840
Morgan Stanley
29
Morgan Stanley
New York
$24K 3,674 +2,174 +145%
Bank of America
30
Bank of America
North Carolina
$22K 3,355 +3,355 New
PA
31
Parallel Advisors
California
$13K 2,000 +2,000 New
EWM
32
Endurance Wealth Management
Rhode Island
$12K 2,000
TRCT
33
Tower Research Capital (TRC)
New York
$9K 1,365 +1,365 New
Fifth Third Bancorp
34
Fifth Third Bancorp
Ohio
$7K 1,000
PCH
35
Polar Capital Holdings
United Kingdom
$5.89K 900,000 -100,000 -10%
HS
36
HighVista Strategies
Massachusetts
-36,638 Closed
DCM
37
DAFNA Capital Management
California
-18,337 Closed
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
-15,035 Closed
PCS
39
Personal CFO Solutions
New Jersey
-10,000 Closed
UBS Group
40
UBS Group
Switzerland
-1,407 Closed
Barclays
41
Barclays
United Kingdom
$0 10 -100 -91%
JPMorgan Chase & Co
42
JPMorgan Chase & Co
New York
-35 Closed
CFGS
43
Concourse Financial Group Securities
Alabama
Citadel Advisors
44
Citadel Advisors
Florida
Simplex Trading
45
Simplex Trading
Illinois
Deutsche Bank
46
Deutsche Bank
Germany
$0 58 +58 New